Greenwich LifeSciences Announces Private Placement Of $2.5M At $14.30 Per Share; Closing Expected On Or About June 18, 2024
Portfolio Pulse from Benzinga Newsdesk
Greenwich LifeSciences (GLSI) announced a private placement of $2.5 million at $14.30 per share with its CEO, Snehal Patel. The closing is expected around June 18, 2024. The proceeds will be used for clinical development and working capital.
June 14, 2024 | 10:07 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Greenwich LifeSciences (GLSI) has entered into a $2.5 million private placement agreement with its CEO, Snehal Patel, at $14.30 per share. The funds will be used for clinical development and working capital.
The private placement will provide GLSI with $2.5 million in funds, which will be used for clinical development and working capital. This is a positive development as it secures necessary funding without incurring investment banking fees. The CEO's involvement and lock-up agreement also indicate strong internal confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100